The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments
Open accessAbstract
Metabolism of neoplastic cells is shifted toward high glucose uptake and enhanced lactate production. Lactate dehydrogenase (LDH), which is comprised of two major subunits, LDH-A and LDH-B, reversibly catalyzes the conversion of pyruvate to lactate or lactate to pyruvate. LDH-A has a higher affinity for pyruvate and is a key enzyme in the glycolytic pathway. Elevated LDH is a negative prognostic biomarker not only because it is a key enzyme involved in cancer metabolism, but also because it allows neoplastic cells to suppress and evade the immune system by altering the tumor microenvironment. LDH-A alters the tumor microenvironment via increased production of lactate. This leads to enhancement of immune-suppressive cells, such as myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), and dendritic cells (DCs); and inhibition of cytolytic cells, such as natural killer (NK) cells and cytotoxic T-lymphocytes (CTLs). By promoting immune-suppression in the tumor microenvironment, LDH-A is able to promote resistance to chemo/radio/targeted therapy. Here we discuss the evidence that LDH is both a metabolic and an immune surveillance prognostic biomarker and its elevation is harbinger of negative outcome in both solid and hematologic neoplasms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
(1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.594 · Cited by 1,929
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Targeting lactate metabolism for cancer therapeutics
Doherty, J. R., & Cleveland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69741 · Cited by 1,166
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Mead, G. M., Stenning, S. P., Cook, P. A., Fosså, S. D., Horwich, A., Kaye, S. B., Oliver, R. T. D., deMulder, P., deWit, R., Stoter, G., et al. (1997) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1,033
Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202702 · Cited by 822
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., & Gabrilovich, D. I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900092 · Cited by 763
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
Gottfried, E., Kunz-Schughart, L. A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., Mackensen, A., & Kreutz, M. (2006) · Blood · doi:10.1182/blood-2005-05-1795 · Cited by 729
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Zamarron, B. F., & Chen, W. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.651 · Cited by 681
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Wojtkowiak, J. W., Verduzco, D., Schramm, K. J., & Gillies, R. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200292c · Cited by 566
Dawson, D. M., Goodfriend, T. L., Kaplan, N. O., & Kaplan, N. O. (1964) · Science · doi:10.1126/science.143.3609.929 · Cited by 548
Xie, H., Hanai, J.-I., Ren, J.-G., Kats, L., Burgess, K., Bhargava, P., Signoretti, S., Billiard, J., Duffy, K. J., Grant, A., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.003 · Cited by 516
Romero-Garcia, S., Moreno-Altamirano, M. M. B., Prado-Garcia, H., & Sánchez-García, F. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00052 · Cited by 506
Effect of NKG2D ligand expression on host immune responses
Champsaur, M., & Lanier, L. L. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00893.x · Cited by 488
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Tran Janco, J. M., Lamichhane, P., Karyampudi, L., & Knutson, K. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403134 · Cited by 440
Zhou, M., Zhao, Y., Ding, Y., Liu, H., Liu, Z., Fodstad, O., Riker, A. I., Kamarajugadda, S., Lu, J., Owen, L. B., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-33 · Cited by 395
An Evidence-based Staging System for Cutaneous Melanoma
Balch, C. M., Soong, S.-J., Atkins, M. B., Buzaid, A. C., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., et al. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.3.131 · Cited by 391
LACTIC DEHYDROGENASE IN HUMAN NEOPLASTIC TISSUES.
Goldman, R. D., Kaplan, N. O., & Hall, T. C. (1964) · PubMed · Cited by 353
Petrelli, F., Cabiddu, M., Coinu, A., Borgonovo, K., Ghilardi, M., Lonati, V., & Barni, S. (2015) · Acta Oncologica · doi:10.3109/0284186x.2015.1043026 · Cited by 323
Ovarian cancer progression is controlled by phenotypic changes in dendritic cells
Scarlett, U. K., Rutkowski, M. R., Rauwerdink, A. M., Fields, J., Escovar-Fadul, X., Baird, J., Cubillos-Ruiz, J. R., Jacobs, A. C., Gonzalez, J. L., Weaver, J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111413 · Cited by 315
Chang, C., Liao, J. C., & Kuo, L. (2001) · PubMed · Cited by 294
Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway
Shime, H., Yabu, M., Akazawa, T., Kodama, K., Matsumoto, M., Seya, T., & Inoue, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7175 · Cited by 285
Kristinsson, S. Y., Björkholm, M., Hultcrantz, M., Derolf, Å. R., Landgren, O., & Goldin, L. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8540 · Cited by 267
Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
Maiso, P., Huynh, D., Moschetta, M., Sacco, A., Aljawai, Y., Mishima, Y., Asara, J. M., Roccaro, A. M., Kimmelman, A. C., & Ghobrial, I. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3400 · Cited by 208
The Warburg Effect Revisited—Lesson from the Sertoli Cell
Oliveira, P. F., Martins, A. D., Moreira, A. C., Cheng, C. Y., & Alves, M. G. (2015) · Medicinal Research Reviews · doi:10.1002/med.21325 · Cited by 185
Crane, C. A., Austgen, K., Haberthur, K., Hofmann, C., Moyes, K. W., Avanesyan, L., Fong, L., Campbell, M. J., Cooper, S., Oakes, S. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413933111 · Cited by 174
Substrate balances across colonic carcinomas in humans.
Holm, E., Hagmüller, E., Staedt, U., Schlickeiser, G., Günther, H.-J., Leweling, H., TOKUS, M., & Kollmar, H. B. (1995) · PubMed · Cited by 168
Thews, O., Gaßner, B., Kelleher, D. K., Schwerd, G., & Gekle, M. (2006) · Neoplasia · doi:10.1593/neo.05697 · Cited by 160
Singer, K., Kastenberger, M., Gottfried, E., Hammerschmied, C. G., Büttner, M., Aigner, M., Seliger, B., Walter, B., Schlösser, H., Hartmann, A., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25543 · Cited by 160
Inhibition of LDHA suppresses tumor progression in prostate cancer
Xian, Z., Liu, J., Chen, Q.-K., Chen, H., Ye, C., Xue, J., Yang, H., Li, J., Liu, X., & Kuang, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3540-x · Cited by 150
LDHC: The Ultimate Testis‐Specific Gene
Goldberg, E., Eddy, E. M., Duan, C., & Odet, F. (2010) · Journal of Andrology · doi:10.2164/jandrol.109.008367 · Cited by 148
Terpos, E., Katodritou, E., Ρούσσου, Μ., Pouli, A. G., Michalis, E., Delimpasi, S., Parcharidou, A., Kartasis, Z., Zomas, A., Symeonidis, A. S., et al. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01466.x · Cited by 147
Emergence of spatial structure in the tumor microenvironment due to the Warburg effect
Carmona‐Fontaine, C., Bucci, V., Akkari, L., Déforet, M., Joyce, J. A., & Xavier, J. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311939110 · Cited by 142
Post-Transplant Lymphoproliferative Disorders
LaCasce, A. S. (2006) · The Oncologist · doi:10.1634/theoncologist.11-6-674 · Cited by 134
Lactic acid delays the inflammatory response of human monocytes
Peter, K., Rehli, M., Singer, K., Renner, K., & Kreutz, M. P. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.005 · Cited by 132
Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer.
Koslowski, M., Türeci, Ö., Bell, C., Krause, P., Lehr, H., Brunner, J., Seitz, G., Nestle, F. O., Huber, C., & Şahin, U. (2002) · PubMed · Cited by 124
Relationships between LDH-A, Lactate, and Metastases in 4T1 Breast Tumors
Rizwan, A., Serganova, I. S., Khanin, R., Karabeber, H., Ni, X., Thakur, S. B., Zakian, K. L., Blasberg, R. G., & Koutcher, J. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3300 · Cited by 122
Metabolic Influences That Regulate Dendritic Cell Function in Tumors
Dong, H., & Bullock, T. N. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00024 · Cited by 96
Brown, J. E., Cook, R. J., Lipton, A., & Coleman, R. E. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1397 · Cited by 87
Hermes, A., Gatzemeier, U., Waschki, B., & Reck, M. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.07.013 · Cited by 74
Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease
García‐Sánz, R., Hernández, J., Caballero, M., González, M., Galende, J., Cañizo, M., Vázquez, L., & Miguel, J. F. S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.509 · Cited by 59
Smit, M. J., Duursma, A. M., Bouma, J. M. W., & Gruber, M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45160-5 · Cited by 55
Tumor cells hijack macrophages via lactic acid
Bronte, V. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.67 · Cited by 38
LDH-C4: a target with therapeutic potential for cancer and contraception
Gupta, G. S. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1428-2 · Cited by 36
Proceedings: The effect of immunosuppression on cancer.
Penn, I., & Starzl, T. E. (1972) · PubMed · Cited by 34
Emadi, A., Sadowska, M., Carter‐Cooper, B., Bhatnagar, V., van der Merwe, I., Levis, M. J., Sausville, E. A., & Lapidus, R. G. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.04.002 · Cited by 17
Self-citation
Cited by
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard, P., Shulman, S., Farhat, D., Steyaert, J.-M., Alifano, M., & Lincet, H. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.001 · Cited by 643
Hay, K. A., Gauthier, J., Hirayama, A. V., Voutsinas, J. M., Wu, Q., Li, D., Gooley, T. A., Cherian, S., Chen, X., Pender, B. S., et al. (2019) · Blood · doi:10.1182/blood-2018-11-883710 · Cited by 404
Hirayama, A. V., Gauthier, J., Hay, K. A., Voutsinas, J. M., Wu, Q., Gooley, T., Li, D., Cherian, S., Chen, X., Pender, B. S., et al. (2019) · Blood · doi:10.1182/blood-2018-11-887067 · Cited by 355
Tumour burden and efficacy of immune-checkpoint inhibitors
Dall’Olio, F. G., Marabelle, A., Caramella, C., Garcia, C., Aldea, M., Chaput, N., Robert, C., & Besse, B. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00564-3 · Cited by 350
Overcoming resistance to tumor-targeted and immune-targeted therapies
Aldea, M., Andre, F., Marabelle, A., Dogan, S., Barlesi, F., & Soria, J.-C. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1638 · Cited by 311
Metadata
- Authors
- Ding, J., Karp, J. E., & Emadi, A.
- Venue
- Cancer Biomarkers
- Publisher
- SAGE Publications
- Published
- 2017-07-04
- Volume
- 19
- Issue
- 4
- Pages
- 353-363
- ISSN
- 1574-0153 (ISSN-L)
- 1875-8592
- OpenAlex
- W2620869065
- Cited by
- 287
- References
- 57
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.